• Les progrès de la recherche sont l'unique espoir pour les patients de trouver des thérapies efficaces!

  • Soutenez la recherche dans le domaine des maladies génétiques rares!

Job opportunity

One post-doctoral position is available at the Medical Faculty, University of Geneva, in the group of Prof. Perrine Castets that will be started in September 2019. The main interests of the group are to understand the molecular mechanisms underlying the loss of muscle function in systemic conditions and neuromuscular diseases.

More information

Rapport d'atelier ENMC

Developing guidelines for management of reproductive options for families with maternally inherited mtDNA disease
22-24 March 2019
disponible en anglais

Diagnosis and management of Juvenile Myasthenia Gravis
1-3 March 2019
disponible en anglais

Towards a European Unifying lab for Kennedy's disease
15-17 février 2019
disponible en français 



Gothenburg, 10-14 June 2019

Challenges in Myotonic Dystrophy – from basic science to therapy

Registration open

Dreiländer-Kongress Mitochondriale Medizin 2019

Zürich, 4.-5. Juli 2019

Hauptthemen des Kongresses sind die Fortschritte in der genetischen Diagnostik und in der Therapieentwicklung bei mitochondrialen Erkrankungen. Neu ist der Wissenschaftspreis 2019 des Deutschen Netzwerks für mitochondriale Erkrankungen (mitoNET) für für den besten Posterbeitrag oder freien Vortrag. 

Anmeldeschluss ist der 15. Juni 2019

Mehr Informationen
Download Einladung
Download Anmeldeformular


Job opportunity

Positions will be available for MSc and PhD studentships, postdoctoral fellows and research associates (lab-based and clinical) at The Ottawa Hospital and University of Ottawa Faculty of Medicine, Canada – please contact us if you are interested in joining the team.

Email us to find out more


Extraocular muscle function is impaired in ryr3 -/- mice.

Eckhardt J, Bachmann C, Sekulic-Jablanovic M, Enzmann V, Park KH, Ma J, Takeshima H, Zorzato F, Treves S.
J Gen Physiol. 2019 May 13

20 mai 2019

Specific inhibition of splicing factor activity by decoy RNA oligonucleotides.

Denichenko P, Mogilevsky M, Cléry A, Welte T, Biran J, Shimshon O, Barnabas GD, Danan-Gotthold M, Kumar S, Yavin E, Levanon EY, Allain FH, Geiger T, Levkowitz G, Karni R.
Nat Commun. 2019 Apr...

17 mai 2019

Pharmacological targeting of age-related changes in skeletal muscle tissue.

Leuchtmann AB, Handschin C.
Pharmacol Res. 2019 Mar 4. pii: S1043-6618(18)31953-4.

02 mai 2019